1White RH, The epidemiology of venous thromboembolism. Circulation, 2003, 107 (23): 4-8.
2Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardio, 2000, 85 (11): 1334-1337.
3Shen MC, Lin JS, Tsay W. High prevalence of antithrombin Ⅲ protein C and protein S deficiency but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan. Throm Res, 1997, 87 (4): 377-385.
4Liu HW, Kwong YL, Bourke C, et al. High incidence of thrombophilia detected in Chinese patients with venous thrombosis. Thromb Haemost, 1994, 71 (4): 416-419.
5Swiatkiewicz A, Jurkowski P, Kotschy M, et al. Level of antithrombin Ⅲ protein C protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis. Med Sci Monit, 2002, 8 (4): 263-268.
6Almawi WY, Borgi-Bouaziz L, Nathalie H, et al. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms. Blood, 2006, 108 (10): 4095.
7Soria JM, Almasy L, Souto JC, et al. Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis. Blood, 2000, 95 (9): 2780-2785.
8Miles JS, Miletich JP, Goldhaber SZ, et al. G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism. J Am CollCardiol, 2001, 37 (1); 215-218.
9Voetsch B, Loscalzo J. Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol, 2004, 24 (2) : 216-229.
10Martin DH, Miranda K. Hyperhomocysteinemia as a risk factor for venous thrombosis. Clin Chem Lab Med, 2001, 39 (8): 710-713.
